Celldex Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

셀덱스 테라퓨틱스NASDAQ:CLDX · Nasdaq · Healthcare

$31.65-1.65%

2026-10-02 close

Celldex Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $7M. 2024 operating profit was −$195M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy